Trial Information
Immuno-enhanced Versus Standard Early Enteral Nutrition Use in Gastrointestinal Postoperative Patients
Inclusion Criteria:
- Resectable gastric cancer by laparoscope
- Resectable colorectal cancer laparoscope
- Resectable gastrointestinal interstitialoma by laparoscope
Exclusion Criteria:
- Locally unresectable tumor
- Metastatic tumor
- Preoperative total parenteral or enteral nutrition
- Lack of the patient's consent for the trial participation
- Previous gastrointestinal resection
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Outcome Measure:
Time to tolerate IEEN/SEEN
Outcome Time Frame:
30 days after operation
Safety Issue:
No
Principal Investigator
Danhua Yao, MD/PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Nanjing University
Authority:
China: Ministry of Health
Study ID:
ISEEN001
NCT ID:
NCT01778166
Start Date:
February 2013
Completion Date:
March 2014
Related Keywords:
- Gastrointestinal Malignant
- Early enteral nutrition
- Laparoscopic gastrointestinal surgery
- Immuno-enhanced nutrition